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ABSTRACT
Toxic nitric oxide (NO) levels can regulate gene
expression. Using a novel protein/DNA array, we
show that toxic NO levels regulate the binding of
trans-factors to various cis-elements in neuroblas-
toma cells, including CRE and those recognized by
the transcription factors AP1, AP2, Brn-3a, EGR,
E2F1 and SP1. Functionality of some of the cis-
elements was confirmed by electro mobility shift
and reporter assays. Interestingly, CREB, AP-1, Brn-
3a, EGR and E2F1 can control mammalian cell
viability. NO induced the anti-apoptotic Bcl-2 pro-
tein and its mRNA prior to the onset of death of
30–60% of the cells. Promoter analysis of the bcl-2
gene confirmed the involvement of a CRE in
NO-dependent bcl-2 transcription. Neuroblastoma
cells over-expressing bcl-2 became much more
resistant to NO-induced apoptosis; conversely,
Bcl-2 knockdown cells were rendered markedly
more sensitive to NO. Together these results
suggest that Bcl-2 counteracts NO-induced apo-
ptosis in a fraction of the cell population. Thus, NO
stimulates the binding of many trans-factors to their
cognate cis-elements, some of which can regulate
cell viability through transcriptional activation of
target genes. Our results emphasize that a DNA/
protein array approach can reveal novel, global
transcription factor activities stimulated by cell
death-regulating molecules.
INTRODUCTION
Nitric oxide (NO) is a ubiquitous signaling molecule
synthesized from L-arginine in an NADPH- and
O2-dependent reaction catalyzed by enzymes termed NO
synthases (NOS) (1). NO is important for a variety of
physiological functions such as vasodilation, fertilization,
diﬀerentiation, inﬂammation and apoptosis (2–4).
NO typically activates soluble guanylyl cyclase in cells to
catalyze the conversion of GTP to cGMP that in turn
activates cGMP-dependent protein kinase and other
kinases, which mediate many of the normal physiological
functions elicited by NO (5).
NO also inﬂuences cell viability either by inducing cell
death when in excess or by protecting cells against
various apoptotic or necrotic insults when present at
more physiological levels (6,7). A predominant view is that
excessive NO exerts cytotoxic eﬀects in diverse cell types by
reacting with superoxide and thereby generating the highly
reactive free radical peroxynitrite, which causes non-
speciﬁc oxidative DNA, protein and lipid damage. Such
damage also triggers downstream signaling pathways and
gene expression, which might elicit either cellular repair or
apoptosis (6,8). A current view is that physiological NO
concentrations can block apoptosis induced by various
agents by activating anti-apoptotic/protective/repair pro-
teins such as DNA-PK catalytic subunit, Bcl-XL,
Bcl-2, cAMP-response element-binding protein (CREB),
NAD(P)H Quinone oxidoreductase or heme oxygenase-1
(9–13). Conversely, excessive NO can elicit apoptosis or
necrosis through a variety of mechanisms involving either
p53-dependent or p53-independent pathways (14–16).
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ingly being recognized as a key post-translational mecha-
nism controlling the functions of certain proteins (17).
There is accumulating evidence of selective S-nitrosylation
of cysteines in proteins that can either block cell death or
promote cell death; and many of these phenomena were
observed in neurons (18,19). NO can regulate gene
expression at least in part through the S-nitrosylation or
phosphorylation of transcription factors or other proteins,
and by regulating the cellular localization of transcription
factors (17). Thus, S-nitrosylation contributes to the
regulation of several pathways, including those leading
to fos/Jun and NF-kB activation (20). Direct S-nitrosyla-
tion of the hypoxia-inducible transcription factor HIF-1a
increases its DNA-binding capacity (17). NO induces
phosphorylation of p53 that promotes its nuclear reten-
tion in neuroblastoma cells (21,22). The roles of NO in
stimulating the functions of other transcription factors
such as EGR-1 and Nrf2, but inhibiting the function of
VDR/RXR, are documented (11,23–27). It is not clear if
all these regulatory mechanisms (e.g. oxidative damage,
S-nitrosylation, transcription) act in concert or indepen-
dently, or function in a cell type-dependent manner. The
actual outcome (cell death or repair) has been attributed
to the particular concentrations of NO, the redox status of
the cell and time-dependent diﬀerential gene regulation.
To reveal the cellular targets of NO under cell death
promoting conditions, it is important to understand not
only the speciﬁc S-nitrosylation events, but also the
signaling pathways activated in response to NO. To this
end, we used a novel protein/DNA array approach to
determine the proﬁles of cis-elements/trans-factors that
respond to apoptosis-inducing concentrations of NO in a
neuronal cell line. We have identiﬁed a number of cis-
elements that bind to various trans-factors in a
NO-regulated fashion, analyzed the patterns of their
regulation, and have begun the identiﬁcation of the
target genes they control in order to reveal the cascade
of NO-dependent gene expression in the control of cell
viability. We show that bcl-2 is a target gene of NO, and
the consequent Bcl-2 up-regulation can limit the amount
of apoptosis induced by toxic levels of NO.
MATERIALS AND METHODS
Materials
The human neuroblastoma cell line SH-Sy5y was obtained
and grown as described previously (28). SNP, DETA-NO,
SIN-1 and other chemicals were obtained from Sigma
Aldrich. Except where stated, the enzymes used in this
study were purchased from New England Biolabs.
Platinum Taq polymerase, 10mM dNTP mix and
Lipofectamine transfection reagent were purchased from
Invitrogen. The pcDNA-bcl-2-myc vector was a gift from
Victor Yu, Institute of Molecular and Cell Biology,
Singapore. The SureSilencing
TM shBcl-2 Plasmid
(targeting sequence in human Bcl-2: 50-GAGGATTGT
GGCCTTCTTTGA-30) was purchased from SuperArray
(KH00079N). The pGL3 Promoter vector containing the
ﬁreﬂy luciferase gene, internal control plasmid pRL-TK
that encodes Renilla luciferase, and the dual luciferase
assay kit were from Promega (Madison, WI, USA). The
Hybond ECL nitrocellulose membrane and ECL Western
blot analysis kit were from Amersham Pharmacia Biotech.
The RNeasy MiniKit was from Qiagen. The nuclear
extraction kit was from Panomics Inc., CA, USA. The
double-stranded oligonucleotides representing the cis-
elements of AP1, AP2, BRN-3, CRE, EGR and SP1 and
their mutants (Table 1), and the antibody against b-actin,
were from Santa Cruz Biotechnology Inc., Santa Cruz,
CA, USA. The antibodies against Bcl-2 were from Upstate
Biotechnology or Santa Cruz Biotechnology. The anti-
bodies against caspase-3 were from Cell Signaling
Technology or Santa Cruz Biotechnology. The
Polyclonal antibody against GAPDH was from Abcam.
The Transignal DNA/Protein Array I and Transcription
Factor cDNA (TF cDNA) array were from Panomics
Inc., CA, USA.
Plasmid construction
The consensus oligonucleotide sequences/mutant
sequences of AP1, AP2, BRN-3, CRE, EGR and SP1 as
Table 1. Oligonucleotide sequences of the various cis-elements and
their mutant derivatives used in the construction of the reporter
plasmids
Cis-element Oligonucleotide sequence
AP1-F 50 CTAG CGC TTG ATG ACT CAG CCG GAA 30
AP1-R 50 TCGA TTC CGG CTG AGT CAT CAA GCG 30
mAP1-F 50 CTAG CGC TTG ATG ACT TGG CCG GAA 30
mAP1-R 50 TCGA TTC CGG CCA AGT CAT CAA GCG 30
AP2-F 50 CTAG GAT CGA ACT GAC CGC CCG CGG CCC
GT 30
AP2-R 50 TCGA AC GGG CCG CGG GCG GTC AGT TCG
ATC 30
mAP2-F 50 CTAG GAT CGA ACT GAC CGC TTG CGG CCC
GT 30
mAP2-R 50 TCGA AC GGG CCG CAA GCG GTC AGT TCG
ATC 30
BRN-3-F 50 CTAG CAC AGC TCA TTA ACG CGC 30
BRN-3-R 50 TCGA GCG CGT TAA TGA GCT GTG 30
mBRN-3-F 50 CTAG CAC AGC TCA GCA ACG CGC 30
mBRN-3-R 50 TCGA GCG CGT TGC TGA GCT GTG 30
CRE-F 50 CTAG AGA GAT TGC CTG ACG TCA GAG AGC
TAG 30
CRE-R 50 TCGA CTA GCT CTC TGA CGT CAG GCA ATC
TCT 30
mCRE-F 50 CTAG AGA GAT TGC CTG TGG TCA GAG AGC
TAG 30
mCRE-R 50 TCGA CTA GCT CTC TGA CCA CAG GCA ATC
TCT 30
EGR-F 50 CTAG GGA TCC AGC GGG GGC GAG CGG
GGG CGA 30
EGR-R 50 TCGA TCG CCC CCG CTC GCC CCC GCT GGA
TCC 30
mEGR-F 50 CTAG GGA TCC AGC TAG GGC GAG CTA GGG
CGA 30
mEGR-R 50 TCGA TCG CCC TAG CTC GCC CTA GCT GGA
TCC 30
Sp1-F 50 CTAG ATT CGA TCG GGG CGG GGC GAG C 30
Sp1-R 50 TCGA G CTC GCC CCG CCC CGA TCG AAT 30
mSp1-F 50 CTAG ATT CGA TCG GTT CGG GGC GAG C 30
mSP1-R 50 TCGA G CTC GCC CCG AAC CGA TCG AAT 30
The mutated core elements are shown in bold and italics.
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vector to generate the reporter plasmids. The sense and
antisense oligonucleotides corresponding to the cis-
elements were synthesized with NheI and XhoI sites,
respectively, and cloned at the respective sites in the pGL3
promoter vector. The reporter plasmids were named
pGL3-AP1 Luc, pGL3-AP2 Luc, pGL3-BRN3 Luc,
pGL3-CRE Luc, pGL3-EGR Luc and pGL3-SP1 Luc.
The mutant reporter plasmids were named pGL3-mAP1
Luc, pGL3-mAP2 Luc, pGL3-mBRN3 Luc, pGL3-mCRE
Luc, pGL3-mEGR Luc and pGL3-mSP1 Luc. The bcl-2
promoter constructs used are described (29).
Protein/DNA arrayanalysis
SH-Sy5y cells were treated with NO donors for the
times indicated, and nuclear proteins were prepared as
described (11). The template of the protein/DNA array
I and the details of the cis-elements present in the array are
described previously (30). The protein/DNA array was
performed following a procedure adapted from that
described (30). Brieﬂy, the nuclear extracts were incubated
with biotin-labeled DNA probe mix in binding buﬀer
for 30min at 158C. Protein/DNA complexes were
resolved in a 2% agarose gel and excised. DNA probes
were recovered from the protein/DNA complexes and
hybridized to the transignal protein/DNA array mem-
brane. Hybridization signals were visualized using
horseradish peroxidase-mediated chemiluminescence.
The experiment was repeated at least two times with two
diﬀerent membranes. The resulting autoradiograph was
scanned by densitometry using a previously described
method (30), and the fold induction/repression was
tabulated along with the standard deviation ( SD)
(Table 2).
Gel shiftassays
SH-Sy5y cells were treated with the NO donors
DETA-NO, SIN1 or SNP for various times up to 8h.
Nuclear extracts were prepared using the nuclear extrac-
tion kit from Panomics. The various cis-elements were
end-labeled with [g-
32P] ATP and T4 polynucleotide
kinase. Bandshift and the competition assays were
performed by previously described procedures (31). Ten
microgram of the nuclear extract was used in the gel shift
assays.
Cellculture andtransfection ofreporter plasmids
The LipofectAMINE transfection reagent kit was used to
transfect the various reporter plasmids in human SH-Sy5y
neuroblastoma cells as described previously (28). The
plasmid pRL-TK encoding Renilla luciferase was used as
an internal control in each transfection. Thirty-six hours
after transfection, the cells were washed three times with
PBS and lysed in Passive Lysis buﬀer from The Dual-
Luciferase Reporter Assay System Kit. The same kit was
used to assay the samples for luciferase activity (31), which
was measured with a TD-20e luminometer.
Transcription factor cDNA arrayanalysis
SH-Sy5y cells were treated with NO donors for the
indicated times, and RNA samples were prepared using a
published method (11). The transcription factor array
(TF array) was performed following the procedure
described (30). Brieﬂy, the probes were synthesized by
combining 10mg of total RNA (isolated from control and
NO-treated SH-Sy5y cells) with 5ml of TF cDNA primer
mix provided by the manufacturer. The total mixture was
heated for 2min at 728C followed by another 2min at
428C. The labeling mix contained 2ml of Biotin-dUTP, 1ml
of reverse transcriptase and 12ml of labeling mixture in
water. The total labeling mix was mixed with the RNA-TF
cDNA primer mix and incubated for 2h at 428C for the
labeling reaction. After 2h, 3ml of the 10  denaturing
solution was added to each sample and incubated for
20min at 688C. Finally, the probe was neutralized by
adding 30mlo f2   Neutralizing Buﬀer and incubating for
10min at 728C. Hybridization of the denatured probe to
the transignal transcription factor cDNA array and
subsequent washes were done according to the manufac-
turer’s instructions. Hybridization signals were visualized
using Streptavidin–HRP conjugate and horseradish per-
oxidase-mediated chemiluminescence. The experiment was
repeated at least two times with two diﬀerent membranes.
Table 2. NO-mediated induction or repression of trans-factor binding
to cis-elements
Cis-element Fold Induction Fold Repression
AP-1 1.98 0.26 –
AP-2 5.20 1.67 –
BRN-3 3.33 0.59 –
CBF 3.75 0.41 –
CDP 1.90 0.30 –
c-myb 4.70 1.40 –
CRE 5.83 0.23 –
E2F1 6.00 1.93 –
EGR 3.25 0.52 –
Ets 1.29 1.10 –
GAS/ 1.95 0.36 –
GATA 5.40 0.42 –
GRE 2.90 0.28 –
MEF-2 – 4.52 0.25
NF-1 1.00 0.08 –
NF-E1 5.00 0.33 –
NF-E2 3.16 0.15 –
1-Oct 1.87 0.04 –
p53 1.32 0.19 -
Pax-5 – –
Pbx-1 3.50 0.48 –
EGR 1.40 0.25 –
PPAR – 1.40 0.30
Sp1 3.02 0.17 –
TFIID – 4.10 0.40
TR 4.07 0.38 –
USF-1 3.41 0.74 –
The cis-elements that mediate signiﬁcant induction or repression after
treatment with the NO donor SNP (2mM) for 4h are tabulated.
The fold of induction or repression was calculated by procedures given
in the Materials and Methods section and represented along with the
standard deviation ( SD).
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Western blot analysis was performed by methods as
described (28). For total protein extraction, the cells were
lysed in a buﬀer containing complete protease inhibitor
cocktail. After centrifugation, 20mg of total proteins were
electrophoresed in 10% polyacrylamide gels and trans-
ferred to an ECL membrane. Immunoblotting was carried
out with antibodies in phosphate-buﬀered saline with
0.2% Tween 20 and 5% BSA. After washing, the
membrane was probed with horseradish peroxidase-
conjugated donkey antiserum to rabbit or mouse
(Chemicon) and developed by the enhanced chemilumi-
nescence method (Amersham Pharmacia Biotech).
Semi-quantitative RT-PCR analysis
Total RNA was extracted from the cells after the NO
donor treatment using the RNA extraction kit from
Qiagen. Semi-quantitative RT-PCR analysis was per-
formed using the one-step RT-PCR kit from Qiagen
using the manufacturer’s protocol. The primers used for
the RT-PCR reactions were as follows. -actin-Forward:
50 atg gat gat gat atc gcc gcg ctc g 30 and Reverse: 50 gaa
gca ttt gcg gtg gac gat gga ggg 30; bcl-2-Forward: 50 acc
atggcgcac gctgggagaa cagg 30 and Reverse 50 cttgtggc
ccagataggc acccaggg 30; bclXL-2-Forward: 50 acc atgtct
cagagcaacc gggagctg 30 and Reverse 50 ttt ccgactgaag agt
gagccca gcag 30; bid-Forward: 50 acc atggactgtg aggtcaacaa
cgg 30 and Reverse 50 gtcca tcccatttct ggctaagctc c 30; bad-
Forward: 50 acc atgttccaga tcccagagtt tgag 30and Reverse
50 ctgg gagggggcgg agcttcccct g 30; fas-Forward: 50 acc
atgctg ggcatctgga ccctcc 30 and Reverse 50 gaccaagct ttgg
atttca tttctgaag 30; fasL-Forward: 50 acc atgcagcagc ccttca
atta cc 30 and Reverse 50 gag cttatataag ccgaaaaacg tctg 30.
In order to ensure the PCR reactions are in the
exponential versus linear phase, we performed the PCR
reactions for each target gene from 18 cycles up to
30 cycles, with 2 cycle intervals, and have carefully
monitored the resulting products. The number of cycles
up to which the product ampliﬁcation is in the linear range
for a particular target is taken into account for
comparison. Accordingly, the cycling conditions used for
the various primer sets were as follows. For -actin, fas
and fasL:5 0 8C for 30min, 958C for 15min, followed by 26
cycles of 958C for 1min, 728C for 2min and a ﬁnal
extension at 728C for 10min. For bcl-2 and bcl-xL, the
same reaction conditions as above were used, but the
ampliﬁcation was performed for only 22 cycles. For bad
and bid:5 0 8C for 30min, 958C or 15min, followed by
25 cycles of 958C for 1min, 628C for 1min, 728C for 1min
and a ﬁnal extension at 728C for 10min.
Stable cell selection, toxicity andenzymatic assays
To knock down Bcl-2, SH-Sy5y cells were stably
transfected with the shBcl-2-containing plasmid using
Lipofectamine
TM 2000, and G418-resistant clones or
vector control clones were isolated as described previously
(32). To generate stable cell lines over-expressing Bcl-2,
the plasmids pcDNA-Bcl-2-myc and the pcDNA vector
were transfected individually in SH-Sy5y cells using
LipofectAMINE 2000 following the manufacturer’s pro-
tocol. The stable cells were selected in medium with 600mg
of neomycin/ml. After selection, the stable clones were
maintained in medium containing 200mg of neomycin/ml.
To measure cell death, the Crystal Violet staining method,
the caspase-3 activity assay or the LDH release assay was
employed as described (32–34). For crystal violet staining,
cells were plated in 6-well plates and either left untreated
or treated with SNP, DETA-NO or SIN1 for 4, 8, 12, 16
and 24h. The cells were stained with 30% Crystal Violet in
10% methanol for 10min. Excess stain was removed
completely by washing with water many times. The cells
were dried, and the stain was eluted in 50% methanol, 1%
acetic acid. Absorbance was measured at 590nm (34). The
activity of caspase-3-like proteases was measured using
microtiter plates as described (32). The LDH release assay
was done according to the published method (33). The
statistical diﬀerences were determined using the Prism
software by one-way analysis of variance (ANOVA)
followed by the Tukey multiple comparison test.
RESULTS
NO induces apoptosis in SH-Sy5y cells
Previous work from our laboratory has demonstrated that
NO induces apoptosis in a concentration and time-
dependent manner in SH-Sy5y neuroblastoma cells
(28,32). SH-Sy5y cells were treated with two diﬀerent
NO donors, SNP (2mM) and DETA-NO (1.5mM) for up
to 24h. Cell death was independently measured by Crystal
Violet staining (Figure 1A) and caspase-3 activation
(Figure 1B), conﬁrming that NO donors (but not the
vehicle control, left panel) induce substantial apoptotic
death, the onset of which is notably delayed by at least 8h.
NO regulates bindingof trans-factorsto acollection
of cis-elements
To identify the cis-elements whose binding to various
trans-factors is regulated by NO, SH-Sy5y cells were
treated with the NO donor SNP (2mM) for 4h. A novel
protein/DNA array (Materials and Methods section) was
used to identify the cis-elements whose binding to cognate
trans-factors is increased or decreased by NO at 4h. This
time point was chosen, because it is prior to cell death
when the cell is expected to be mounting transcriptional
responses to the insult, but before the actual decision to
survive or undergo apoptosis is taken. Table 2 shows that
NO increased the binding of trans-factors to a collection
of cis-elements from  1- to 6-fold. The maximum increase
of 6-fold was observed with the E2F1 element, followed by
elements such as GATA, AP2, NF-E1 and CRE ( 5-fold)
(Figure 2A and Table 2). A moderate increase of  2- to
4-fold was observed with elements such as AP1, BRN-3,
CBF, CDP, c-myb, NF-E2, PBX-1, EGR, GRE, SP1, TR
and USF-1, whereas elements such as PPAR, MEF-2 and
TFIID showed a moderate decrease in trans-factor
binding ( 1- to 4-fold) (Figure 2A and Table 2).
Elements such as SMAD and STAT did not show any
increase or decrease in trans-factor binding with NO
treatment (Figure 2A).
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elements observed with the protein/DNA hybrid array
was subsequently conﬁrmed by EMSA for some of the cis-
elements (Figure 2B and C). We could not perform a
conﬁrmation for all the cis-elements that showed increases
or decreases in binding in the array because of the large
number of samples. For the EMSA, we used more than
one NO donor (SIN1, SNP, DETA-NO) to conﬁrm that
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elements is consistent irrespective of the donor com-
pounds. The experiments were also done with diﬀerent
concentrations (0.5–2mM) of NO donors at four diﬀerent
time points. All the NO donors increased the binding of
trans-factors to the cis-elements AP1, AP2, CRE, EGR
and SP1 very substantially (Figure 2B and C), and the
magnitude of the increases was comparable to that
observed with the protein/DNA array (Figure 2A and
Table 2), though it was not identical. There was no
consistent increase in the trans-factor binding to BRN-3.
The competition assays with the cold (unlabeled) mutant
oligonucleotides and the cold wild-type oligonucleotides
showed that only the wild-type oligonucleotides could
compete for binding (Figure 2D). This clearly shows the
speciﬁcity of binding. Thus, the EMSA results conﬁrm the
NO-mediated increase in binding of trans-factors to many
of the cis-elements observed with the protein/DNA array.
We next addressed whether the increase in the binding
of trans-factors to cis-elements observed with the protein/
DNA array and the EMSA translated into transcriptional
activation or repression. Reporter plasmids carrying the
luciferase gene linked to the various cis-elements or their
mutated non-consensus sequences were constructed and
used in transient transfection assays. Table 1 lists the
oligonucleotides harboring the cis-elements and their
mutants used in the construction of the reporter plasmids.
The reporter plasmids pGL3-AP1 Luc, pGL3-AP2 Luc
and pGL3-CRE Luc mediated a signiﬁcant basal activity,
which was strongly induced upon NO treatment (SNP
2mM) in a time-dependent manner (Figure 3). The
NO-induced activation observed with the various repor-
ters after 12h of NO treatment were  5-fold for AP1,
 3-fold for AP2 and  12-fold for CRE (Figure 3, upper
panels). The reporter plasmids pGL3-BRN3 Luc, pGL3-
EGR Luc and pGL3-SP1 Luc also showed a substantial
basal activity. However, the signiﬁcant and sustained
NO-mediated induction of transcriptional activity seen
with the AP1, AP2 and CRE cis-element reporters upon
NO treatment was not seen with BRN-3, EGR and SP1
(Figure 3, lower panels). The reporter plasmid
pGL3-BRN3 Luc showed  1.5-fold activation 2h after
NO treatment, which reduced sharply after 2h and
reached the basal level by  8–12h. The reporter plasmid
pGL3-EGR Luc showed very marginal  0.2-fold activa-
tion by 2h, but showed  1-fold repression by  8–12h
after NO treatment. The reporter plasmid pGL3-SP1 Luc
did not show any signiﬁcant activation upon NO
treatment (Figure 3). The reporter assays were carried
out at least three times with all three NO donors. The data
presented in Figure 3 show the representative results
obtained using SNP (2mM) as the NO donor, although
the results obtained from all three NO donors showed
similar patterns. In pilot experiments with the transient
transfections, 0.5–2.0mg of the diﬀerent reporter con-
structs were used, but the fold responses remained very
similar (data not shown). This indicates a true result and
not an artifact of transfecting excessive amounts of the
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Figure 3. Eﬀect of NO on transcriptional activation/repression mediated by the various cis-elements. Various cis-elements were cloned into the pGL3
vector with luciferase under the control of the SV40 promoter. SH-Sy5y cells were transfected with 0.5mg of the various reporter plasmids along with
0.05mg of the plasmid pRL-TK encoding Renilla luciferase. At 36h post-transfection, the cells were treated with the NO donor SNP (2mM) for the
indicated times and analyzed for luciferase activity. The values represent mean SE of three independent transfection experiments.
5444 Nucleic Acids Research, 2007, Vol. 35, No. 16reporter plasmids. Reporter assays with the plasmids
carrying the mutant cis-elements did not exhibit any
substantial basal activity, and the induction with the NO
donors was completely abolished (data not shown).
Hence, these results show that although NO activates
the binding of transcription factors to a collection of cis-
elements, not all these elements mediate transcriptional
activation or repression.
Unchanged proteinexpression of transcription factors
that bindto cis-elements
NO might induce or repress de novo transcription of the
trans-factors that bind to the cis-elements, thereby
contributing to the activation or repression observed
with the protein/DNA array, EMSA and reporter assays.
To address this issue, we employed a transcription factor
cDNA array to measure the NO-regulated transcription
factor expression levels. Overall, we did not observe any
signiﬁcant changes in the mRNA expression proﬁles of the
clear majority of the transcription factors upon NO
treatment using SNP (2mM) as the NO donor
(Figure 4). A slight increase in the NO-induced mRNA
levels was observed with fosB and junB, whereas a
decrease in mRNA levels was seen with junD and EGR2
(Figure 4). Thus, it cannot be ruled out that the
NO-mediated reduction in EGR-Luc activity (Figure 3)
may be due to lower expression of EGR2 induced by NO
(Figure 4B). Nevertheless, we infer that NO mostly
stimulates the binding of pre-formed transcription factors
to various cis-elements, for example, by post-translational
modiﬁcations (at the very least for AP-1, AP-2, CRE and
Brn-3a), which consequently regulates gene transcription.
The bcl-2 gene isatranscriptional targetof NO
Is the NO-mediated transcriptional activation we
observed mediated by the cis-elements physiologically
relevant in terms of speciﬁc gene transcription? To identify
the NO-regulated pro- and anti-apoptotic genes that
harbor these cis-elements in their promoter regions, a
semi-quantitative RT-PCR analysis was performed for the
following genes—bid, bad, bcl-xL, fas, fasL and bcl-2
(these genes were selected for the analysis based on the
fact that they have some of the cis-elements that we
identiﬁed in our array in their promoter regions). No
changes in the transcriptional proﬁles of bid, bcl-xL,
(Figure 5) or bad, fas, fasL (data not shown) were
observed with any of the NO donors. However, the
transcript of the anti-apoptotic gene bcl-2 was signiﬁ-
cantly up-regulated as early as 2h by all three NO
donors (Figure 5A). Additional experiments done with
IMR-32 neuroblastoma cells also showed a signiﬁcant
up-regulation of the bcl-2 gene as early as 2h after
treatment with the three NO donors (data not shown).
An  2.5- to 4-fold induction of Bcl-2 protein was
observed, which began as early as 2h after SNP or
DETA-NO treatment (Figure 5B). These experiments
together suggest that the bcl-2 gene is a transcriptional
target of NO.
Cyclic AMPresponse element (CRE) mediates
transcriptional regulation ofbcl-2 by NO
The bcl-2 gene promoter comprises P1 and P2 regions and
has characterized cis-elements viz., one CRE and two SP1
sites located upstream of the P1 promoter that determine
the basal and inducible expression (Figure 6) (29). The
various bcl-2 promoter constructs used in this study have
been described (29) and are shown schematically in
Figure 6A. SH-Sy5y cells were transfected with various
full-length and truncated or mutated reporter plasmids.
The full-length (P1+P2) plasmid LB 322 harboring the
bcl-2 gene promoter showed  1.5-fold inducible reporter
activity with DETA-NO (1.5mM) (Figure 6B). The
construct LB 124 that comprises only the P1 region of
the bcl-2 promoter retained the basal and NO-inducible
activity of the full-length construct (LB 322: P1 plus P2).
However, the construct LB 335, which has only the P2
region of the bcl-2 promoter, did not mediate any
induction with NO (Figure 6B). In other words, the
induction seen with the full-length construct (LB 322)
upon NO treatment is solely from the P1 region and not
from the P2 region of the bcl-2 promoter.
To further characterize the cis-elements in the P1 region
that respond to NO, a series of truncated and mutated
reporter plasmids were used. The deletion construct LB
334 with two SP1 elements and one CRE element
(Figure 6A) displayed similar basal and NO-inducible
luciferase activity as that of the full-length (LB 322) and
the P1 construct (LB 124) (Figure 6C). However, when the
CRE element was mutated (LB 595), the basal activity was
retained but the induction by DETA-NO (1.5mM) was
completely lost (Figure 6C). The constructs with a
mutation in the proximal SP1 site (LB 1263) or the
distal SP1 site (LB 1283) behaved in a similar manner to
the full-length (LB 322) and truncated P1 (LB 124)
promoter constructs (Figure 6C). Figure 6D shows that
experiments with SNP (2mM) as NO donor gave similar
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Figure 4. Eﬀect of NO on the expression of transcription factors.
(A and B) SH-Sy5y cells were treated with the NO donor SNP (2mM)
for 4 and 8h, and the transcription factor array was performed as
described in the Materials and Methods section. The subsequent
expression proﬁles of the selected transcription factors (representing
mRNA levels) are shown.
Nucleic Acids Research, 2007, Vol. 35, No. 16 5445results as those in Figure 6C. These data strongly
implicate the CRE element in NO-mediated bcl-2 gene
induction.
Bcl-2 counteracts NO-induced apoptosis of SH-Sy5y cells
NO is known to induce apoptosis of SH-Sy5y cells in a
time and concentration-dependent manner (Figure 1)
(28,32). To study the functional relevance of CRE-
mediated up-regulation of the bcl-2 gene in NO-induced
apoptosis, stable cells expressing bcl-2 were generated, and
two independent clones were selected and characterized
(Figure 7). Two independent stable cell lines expressed
higher levels of Bcl-2 protein as compared to the vector
control cells (Figure 7A, left panel). The NO donors SNP
(2mM) and DETA-NO (1.5mM) induced  30–70% cell
death in the wild-type and vector control cells (Figure 7B),
and caspase-3 activity was maximal by 12h after NO
treatment with SNP (2mM) and DETA-NO (1.5mM)
(Figure 7C). In contrast, both independent stable cell lines
expressing higher levels of Bcl-2 protein were substantially
(60–70%) protected from NO-induced cell death
(Figure 7B). In accord with this result, the bcl-2 stable
cells exhibited a complete loss of caspase-3 activity, even
at 16h after NO stimulation (Figure 7C), and caspase-3
cleavage was strongly inhibited in these cells (Figure 7A,
right panel).
To corroborate these results and to address whether
endogenous Bcl-2 can counteract NO-induced apoptosis,
we knocked down Bcl-2 using a commercially validated
shRNA (Materials and Methods section). Three individ-
ual Bcl-2 knockdown stable clones were generated, two of
which almost totally abolished Bcl-2 synthesis
(Figure 8A). In time course experiments, all three Bcl-2
knockdown clones exhibited increased NO-induced cell
death and caspase-3 activity compared with the parental
and vector control cells (Figure 8B and C). Consistent
with Figure 8C, all three clones produced greater levels of
caspase-3 cleaved fragments, indicative of caspase-3
activation (Figure 8D). Interestingly clone 1, which had
the least Bcl-2 knockdown, showed levels of cytotoxicity,
caspase-3 activity and caspase-3 cleaved fragments that
were intermediate between the vector control and the fully
knocked down clones 1 and 2.
Thus, the experiments in Figures 7 and 8 together
illustrate the functional importance of NO-induced
bcl-2 up-regulation and Bcl-2 synthesis (Figure 5) in
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5446 Nucleic Acids Research, 2007, Vol. 35, No. 16counteracting NO-mediated apoptosis of neuroblastoma
cells.
DISCUSSION
The plethora of responses elicited by toxic levels of NO
may be determined by the particular reactive nitrogen
intermediate, chemical modiﬁcations (e.g. S-nitrosylation)
(17,18), or signal transduction pathways leading to
transcriptional activation and gene expression that are
increasingly being recognized as important aspects of the
pleiotropic actions of NO (3,8,18). As will be discussed
below, an emerging view is that excessive NO concentra-
tions can simultaneously induce cell death promoting
and counteracting signaling pathways, the balance and
timing of which will determine whether the cell survives
or dies.
The interactions of transcription factors with cis-acting
regulatory elements may be considered the ultimate step in
signal transduction pathways. Studies on NO-mediated
transcriptional regulation have identiﬁed a very wide
range of genes induced or repressed by NO in a cell-
speciﬁc manner, anticipating that correspondingly diverse
numbers of transcription factors may be involved in their
expression or repression (3,8,16). In general, identiﬁcation
of transcription factors and their target genes has up till
now been cumbersome; and not surprisingly, few studies
have succeeded in addressing the actual cis-elements
required for the physiological signiﬁcance and target
genes of the transcription factors activated by NO.
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Nucleic Acids Research, 2007, Vol. 35, No. 16 5447Nevertheless, several transcription factors are known to be
involved in NO-induced neuronal cell death or diﬀerentia-
tion. These include c-Jun/AP-1 (bi-potential regulator of
cell viability), CREB (which up-regulates protective Bcl-
2), E2F (which down-regulates N-Myc in diﬀerentiation)
and p53 (which up-regulates several pro-apoptotic
genes)(6,7,28,32,35,36).
We used a novel protein/DNA array to investigate the
cis-elements that display altered binding to cognate trans-
factors in response to NO, identiﬁed a collection of cis-
elements whose binding to trans-factors is regulated
by NO, and analyzed their relevance to gene transcription
in some cases. NO does not functionally activate trans-
factor binding to all the known cis-elements; moreover,
some cis-elements mediate gene activation, while others
mediate gene repression, indicating that the eﬀects that we
observed are not non-speciﬁc. Most of the cis-elements in
the array exhibited increased compared with decreased
trans-factor binding, and some were conﬁrmed by EMSA
using diﬀerent NO donors in varying concentrations.
Although increased DNA binding was seen with some cis-
elements, only a subset of them might have physiological
relevance in terms of gene activation or repression as
revealed by reporter assays.
Our transcription factor array analysis revealed CRE as
one of the cis-elements whose binding to cognate trans-
factors is strongly activated by NO, which conﬁrmed our
previous studies showing c-Jun/AP1 factors regulate
NO-mediated cell survival and cell death in SH-Sy5y
neuroblastoma cells (28,32), and also validates the whole
array approach. In addition to c-Jun/AP1, the transcrip-
tion factors AP-2, CREB, Brn-3a, Brn-3b and E2F have
also been implicated in cell survival and cell death in
various cell types (37–42). Hence, it is not surprising that
we ﬁnd that excessive NO activates the cis-elements that
are bound by these transcription factors.
One of the novel and surprising ﬁndings in the present
study is that NO induces a substantial  2- to 3-fold
increase in the activity of AP2, a transcription factor
mainly associated with the regulation of gene expression
during development (43). AP2-regulated genes include
those encoding p21
WAF1/CIP1, c-Myc, TGF-a and c-Kit,
which control cell division, diﬀerentiation or apoptosis
(44–47). The cranial defects in the developing neuroe-
pithelium and neural crest in AP-2a-deﬁcient mice have
been attributed, at least in part, to increased cell
death (43). Moreover, AP-2 may act to attenuate
c-Myc-dependent apoptosis under adverse conditions (44).
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5448 Nucleic Acids Research, 2007, Vol. 35, No. 16The NO-mediated activity proﬁle of BRN-3 and EGR is
unique in the sense that there is an initial moderate spike
in trans-factor activity at the early time point (2h)
followed by a steady decrease in activity (from 4 to 12h)
(Figure 3). If indeed this translates to an in vivo eﬀect in
gene transcription it would be an interesting phenomenon
of gene expression increasing in the early hours and
decreasing steadily during the late hours following NO
stress. In fact, this kind of gene proﬁle has been reported
for genes following various signaling events (3). Hence, it
would be interesting to explore the downstream target
genes harboring BRN-3 and EGR elements that respond
to NO. In fact, some EGR- and Brn-3-regulated apoptotic
genes are known, which provides a possible starting point
(42,48,49). For instance, among the Brn-3 family of
transcription factors, Brn-3a and Brn-3b are known to
have diﬀerent, sometimes antagonistic eﬀects on speciﬁc
promoters (41). Moreover, both Brn-3a and Brn-3b
bind to p53 in neuroblastoma cells, but Brn-3a is
associated with survival, growth arrest and diﬀerentiation,
whereas Brn-3b enhances p53-mediated apoptosis (41).
Another interesting ﬁnding in our study is the
NO-mediated repression mediated through the
cis-elements such as MEF-2, PPAR and TFIID.
The cognate trans-factors for MEF-2 and TFIID were
not known to be regulated by NO, and the signiﬁcance of
this repression by NO remains unknown (50,51). On the
other hand, the response of the PPAR element to NO has
been documented (52). More interestingly, the iNOS
promoter has a functional PPAR-binding element (53).
Hence a negative feedback regulation of NO synthesis by
NO is possible through the PPAR element. However, this
hypothesis needs to be veriﬁed experimentally. The data
obtained with the SP1 reporters suggest that there is no
obvious NO-regulated transactivation or transrepression.
This ﬁnding suggests that although there is a strong
increase in cis-element-trans-factor binding following NO
treatment in the SP1 array and EMSA, it does not
translate into an increase or decrease in transcriptional
activity. The signiﬁcance of the increase in DNA binding
in the absence of any substantial change in transcriptional
activity remains to be determined.
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Nucleic Acids Research, 2007, Vol. 35, No. 16 5449Finally, using the anti-apoptotic Bcl-2 protein as an
example, we demonstrated that toxic concentrations of
NO induce bcl-2 mRNA and subsequently its protein via a
CRE element in the bcl-2 promoter. Interestingly, muta-
tion in the CRE element did not aﬀect the basal expression
of the bcl-2 gene, implying that the CRE may not play any
signiﬁcant role in regulating the basal expression of the
bcl-2 gene in SH-SY5Y cells (Figure 6). Cyclic AMP
response element binding protein (CREB) is a major
protein that binds to the CRE element. There is
evidence that non-toxic levels of NO induce protection
from apoptosis via CREB phosphorylation, CRE
binding and consequent Bcl-2 up-regulation in neuronal
cells (10,19,35). Lethal levels of NO donors might also
activate gene expression via CREB (54); thus, it is entirely
possible that CREB mediates NO-induced Bcl-2
up-regulation in the present study. Indeed, using lethal
levels of NO donors, we showed Bcl-2 is up-regulated and
trans-factor binding to CRE elements are both increased
well before  30–60% cell death is evident. Even the
amount of induced Bcl-2 is obviously not suﬃcient to
prevent this (incomplete) cell death occurring in the
parental cells, since over-expression of Bcl-2 totally
prevents apoptosis. Conversely, complete knockdown of
Bcl-2 not only sensitizes the cells to apoptosis at later time
points, but also causes a much earlier activation of
caspases—an indicator of the impending increased apop-
tosis. Although Bcl-2 is still induced at later time points
when many of the cells (30–60%) are dying, we speculate
this induction is occurring in the surviving cells.
Thus, we conclude Bcl-2 successfully counteracts
NO-induced cell death in a signiﬁcant fraction of
neuroblastoma cells. In other words, it is likely that the
up-regulation of Bcl-2 by NO both delays the onset of
apoptosis and limits the number of cells that succumb to
NO. Our ﬁndings are in accord with previous studies
which hinted at a role for Bcl-2 by demonstrating a
correlation between Bcl-2 levels and resistance of cells to
NO-induced apoptosis (35,55,56). We have previously
demonstrated that toxic NO levels stimulate the early
transcriptional activation of the transcription factor Nrf2,
which mitigates apoptosis of neuroblastoma cells via the
synthesis of protective and anti-oxidant proteins (11).
Thus, our functional analysis suggests that like Nrf2,
NO-mediated Bcl-2 synthesis contributes to the overall
cellular defense against excessive NO.
Overall our ﬁndings implicate a role for gene expression
mediated by various cis-elements in delaying, counter-
acting or promoting apoptosis. Whether all the identiﬁed
transcription factors and their cis-elements act in concert
or independently needs to be investigated, though the
failure of the majority of the tested transcription factors
themselves to be regulated at the mRNA level by NO
tends to argue that in the main, de novo transcription is
induced or repressed by various preformed transcription
factors downstream of various signal transduction
pathways.
In summary, we show a DNA/protein array approach
can readily reveal novel, global and functionally impor-
tant transcription factor activities stimulated by signaling
and toxic molecules or indeed any stimulus external to the
cell. In general, the use of speciﬁc inhibitors of signaling
proteins or knockout cells, combined with the array
approach, will now allow us to determine whether
particular signaling pathways are essential for regulating
gene expression via one or more deﬁned transcription
factors.
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